Chicago Partners Investment Group’s Ironwood Pharmaceuticals IRWD Stock Holding History

Chicago Partners Investment Group’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$77.3K	Buy	+18,483	New	+$75.8K	﹤0.01%	1403

Other funds holding IRWD

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Chicago Partners Investment Group's IRWD Position: Q1 2026 in Review

Chicago Partners Investment Group opened a new position in Ironwood Pharmaceuticals (IRWD) in Q1 2026: 18,483 shares worth $77.3K. The stake represents ﹤0.01% of the portfolio and ranks #1403 among its holdings.

226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

Chicago Partners Investment Group held 18,483 shares of Ironwood Pharmaceuticals worth $77.3K as of Q1 2026.
Ironwood Pharmaceuticals was a new Chicago Partners Investment Group position in Q1 2026.
Ironwood Pharmaceuticals made up ﹤0.01% of Chicago Partners Investment Group's portfolio in Q1 2026, its #1403 holding.
226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Chicago Partners Investment Group's 13F filing for Q1 2026, filed 4 May 2026.